INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 86 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $13,000 | -82.4% | 5,000 | -88.0% | 0.00% | – |
| Q3 2017 | $74,000 | -48.6% | 41,500 | -45.0% | 0.00% | – |
| Q2 2017 | $144,000 | -46.7% | 75,502 | -44.0% | 0.00% | – |
| Q1 2017 | $270,000 | -62.8% | 134,864 | +13.1% | 0.00% | – |
| Q4 2016 | $726,000 | +374.5% | 119,238 | +637.1% | 0.00% | – |
| Q3 2016 | $153,000 | +88.9% | 16,176 | +48.7% | 0.00% | – |
| Q2 2016 | $81,000 | -86.3% | 10,877 | -86.3% | 0.00% | – |
| Q1 2016 | $590,000 | +249.1% | 79,653 | +434.7% | 0.00% | – |
| Q4 2015 | $169,000 | +196.5% | 14,898 | +143.6% | 0.00% | – |
| Q3 2015 | $57,000 | +1040.0% | 6,115 | +511.5% | 0.00% | – |
| Q2 2015 | $5,000 | -94.8% | 1,000 | -94.5% | 0.00% | – |
| Q1 2015 | $97,000 | – | 18,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |